Wulff-Erik von Borcke is Senior Vice President, AbbVie and President, Oncology. Mr. von Borcke is responsible for the Oncology commercial business in the United States and the global Oncology commercial strategy.
Prior to this role, Mr. von Borcke has held multiple leadership roles of increasing responsibility. He was previously President of Pharmacyclics LLC, a subsidiary of AbbVie, until its full integration into AbbVie. Prior to his role with Pharmacyclics, he was Vice President, Global Marketing, where he led global marketing across all therapeutic areas.
Prior to the company’s separation from Abbott, Mr. von Borcke was Divisional Vice President, Global Marketing, and held several leadership positions within the global pharmaceutical business, including General Manager, Abbott Germany; Divisional Vice President/General Manager, Immunology franchise in the United States; and General Manager, Humira, International Marketing.
Mr. von Borcke completed his formal education in Germany and Spain. He obtained degrees in business administration at the ESB Business School in Reutlingen, Germany, and the ICADE Business School in Madrid, Spain.